Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease - Japanese multi-center study

International Journal of Cardiology

Volumn 120, Issue 1, 2007, Pages 72-78

  Sakazaki, Hisanori ^a   Niwa, Koichiro ^b   Echigo, Shigeyuki ^c   Akagi, Teiji ^d   Nakazawa, Makoto ^e  

^a Hyogo Prefectural Amagasaki Hospital   (Japan)

^b CHIBA CARDIOVASCULAR CENTER   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e Southern Tohoku General Hospital and Southern Tohoku Research Institute for Neuroscience   (Japan)

Author keywords

Cyantic congenital heart disease; Hypoxemia; Morbidity; Mortality

Indexed keywords

OXYGEN;

ADOLESCENT; ADULT; ARTICLE; ATRIOVENTRICULAR CANAL; BRAIN INFARCTION; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMATOCRIT; HEMOPTYSIS; HOSPITALIZATION; HUMAN; INCIDENCE; JAPANESE; LUNG EMBOLISM; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; OXYGEN SATURATION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; SURVIVAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYANOSIS; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HOSPITALIZATION; HUMANS; INFANT; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 34347273346     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.08.081     Document Type: Article

References (43)

1. Niwa K., Perloff J.K., Webb G.D., et al. Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol 96 (2004) 211-216
2. Perloff J.K., Rosove M.H., Sietsema K.E., and Territo M.C. Cyanotic congenital heart disease: a multisystem disorder. In: Perloff J.K., and Child J.S. (Eds). Congenital heart disease in adults. 2nd ed. (1998), WB Saunders, Philadelphia 199-226
3. Saha A., Balakrishnan K.G., Jaiswal P.K., et al. Prognosis for patients with Eisenmenger syndrome of various aetiology. Int J Cardiol 45 (1994) 199-207
4. Perloff J.K., Rosove M.H., Child J.S., et al. Adults with cyanotic congenital heart disease: hematologic management. Ann Intern Med 109 (1988) 406-413
5. Vongpatanasin W., Brickner M.E., Hills L.D., et al. The Eisenmenger syndrome in adults. Ann Intern Med 128 (1998) 745-755
6. Daliento L., Somerville J., Presbitero P., et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 19 (1998) 1845-1855
7. Niwa K., Perloff J.K., Kaplan S., et al. Eisenmenger syndrome in adult: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol 34 (1999) 223-232
8. Cantor W.J., Harrison D.A., Moussadji J.S., et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 84 (1999) 677-681
9. Oya H., Nagaya N., Miyatake K., et al. Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome. Heart 84 (2000) 53-58
10. Oya H., Nagaya N., Miyatake K., et al. Poor prognosis and related factors in adults with Eisenmenger syndrome. Am Heart J 143 (2002) 739-744
11. Rosenzweig E.B., and Barst R.J. Eisenmenger syndrome: current management. Prog Cardiovasc Dis 45 (2002) 129-138
12. Silversides C.K., Webb G.D., Therrien J., et al. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 42 (2003) 1982-1987
13. Oechslin E.N., Harrison D.A., Connelly M.S., Webb G.D., and Siu S.C. Mode of death in adults with congenital heart disease. Am J Cardiol 80 (2000) 1111-1116
14. Warnes C.A., and Somerville J. Tricuspid atresia in adolescents and adults: current state and late complications. Br Heart J 56 (1986) 535-543
15. Marelli A.J., Perloff J.K., and Child J.S. Pulmonary atresia with ventricular septal defect in adults. Circulation 89 (1994) 243-251
16. Kopf G.S., Laks H., Stansel H.C., et al. Thirty-year follow-up of superior vena cava-pulmonary artery (Glenn) shunts. J Thorac Cardiovasc Surg 100 (1990) 662-671
17. Gatzoulis M.A., Munk M.D., Williams W.G., et al. Definitive palliation with cavopulmonary or aortopulmonary shunts for adults with single ventricle physiology. Heart 83 (2000) 51-57
18. Jaiswal P.K., Balakrishnan K.G., Saha A., et al. Clinical profile and natural history of Ebstein's anomaly of tricuspid valve. Int J Cardiol 46 (1994) 113-119
19. Hager A., Kaemmerer H., et al. Long-term survival of patients with univentricular heart not treated surgically. J Thorac Cardiovasc Surg 123 (2002) 1214-1217
20. Cox D.R. Regression models and life tables. J R Stat Soc B 34 (1972) 187-220
21. Bergstaralh E.J., and Offord K.P. Conditional probability used in calculating cohort expected survival. Technical report series, number 37 (1988), Mayo Clinic Section of Medical Research Statistics, Rochester, Minnesota
22. Perloff J.K., Marelli A.J., and Miner P.D. Risk of stroke in adults with cyanotic congenital heart disease. Circulation 87 (1993) 1954-1959
23. Ammash N., and Warnes C.A. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 28 (1996) 768-772
24. Engelfriet P., Boersma E., Oechslin E., et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. Eur Heart J 26 (2005) 2325-2333
25. Clarkson P.M., Frye R.L., Dushane J.W., et al. Prognosis for patients with ventricular septal defect and severe pulmonary vascular obstructive disease. Circulation 38 (1968) 129-135
26. Kidd L., Driscoll D.J., Gersony W.M., et al. Second natural history of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation 87 Suppl I (1993) I38-I51
27. Himeno W. Angiogenic growth factors in patients with cyanotic congenital heart disease and in normal children. Kurume Med J 48 2 (2001) 111-116
28. Dittrich S., Haas N.A., Buhrer C., Muller C., Dahnert I., and Lange P.E. Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr 87 (1998) 949-954
29. Passwell J., Orda S., Modan M., Shem-Tov A., Aladjem M., and Boichis H. Abnormal renal functions in cyanotic congenital heart disease. Arch Dis Child 51 (1976) 803-805
30. Wilcox C.S., Payne J., and Harrison D.W. Renal function in patients with chronic hypoxaemia and cor pulmonale following reversal of polycythaemia. Nephron 30 (1982) 173-177
31. De Jong P.E., Weening J.J., Donker J.M., and van der Hem G.K. The effect of phlebotomy on renal function and proteinuria in a patient with congenital cyanotic heart disease. Nephron 33 (1983) 225-226
32. Phornphutkul C., Rosenthal A., Nadas A.S., and Berenberg W. Cerebrovasular accidents in infants and children with cyanotic congenital heart disease. Am J Cardiol 32 (1973) 329-334
33. Cottrill C.M., and Kaplan S. Cerebral vascular accidents in cyanotic congenital heart disease. Am J Dis Child 125 (1973) 484-487
34. LinderKamp O., Hlose H.J., Betke K., Brodherr-Heberlein S., Buhlmeyer K., Kelson S., and Sengespeik C. Increased blood viscosity in patients with cyanotic congenital heart disease and iron deficiency. J Pediatr 95 (1979) 567-569
35. Trowbridge E.A., Martin J.F., and Slater D.N. Evidence for a theory of physical fragmentation of megakaryocytes implying that all platelets are produced in the pulmonary circulation. Thromb Res 28 (1982) 461-475
36. Horigome H., Hiramatsu Y., Shigeta O., Nagasawa T., and Matsui A. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. J Am Coll Cardiol 39 (2002) 1072-1077
37. Lill M.C., Perloff J.K., and Child J.S. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol 98 2 (2006) 254-258
38. Corno A.F., Milano G., Smaja M., Tozzi P., and von Segesser L.K. Chronic hypoxia: a model for cyanotic congenital heart defects. J Thorac Cardiovasc Surg 124 (2002) 105-112
39. Silverman N.A., Kohler J., Levitsky S., Pavel D.G., Fang R.B., and Feinberg H. Chronic hypoxemia depresses global ventricular function and predisposes to the depletion of high-energy phosphates during cardioplegic arrest: implications for surgical repair of cyanotic congenital heart defects. Ann Thorac Surg 37 (1984) 304-308
40. Hopkins W.E., Waggoner A.D., and Gussak H. Quantitative ultrasonic tissue characterization of myocardium in cyanotic adults with an unrepaired congenital heart defect. Am J Cardiol 74 (1994) 930-934
41. Hu J., Sun P., Ruan X., Chao A., Lin Y., and Li X.Y. Mechanism of myocardial microvessel formation in cyanotic congenital heart disease. Circ J 69 (2005) 1089-1093
42. Tremper K.K., and Barker S.J. Pulse oximetry. Anesthesiology 70 (1989) 98-108
43. Nickerson B.G., Sarkisian C., and Tremper K. Bias and precision of pulse oximeters and arterial oximeters. Chest 93 3 (1988) 515-517